We are live on ! Find out more
DSC

Duncker Streett & Co Portfolio holdings

AUM $526M
1-Year Est. Return 22.2%
This Fund
S&P 500
This Quarter Est. Return
-0.23%
1 Year Est. Return
+22.2%
3 Year Est. Return
+74.69%
5 Year Est. Return
+94.09%
10 Year Est. Return
+300.66%
AUM
$293M
AUM Growth
-$15.8M
Cap. Flow
-$13.4M
Cap. Flow %
-4.57%
Top 10 Hldgs %
18.15%
Holding
649
New
59
Increased
108
Reduced
207
Closed
18

Sector Composition

Rank Sector Weight
1 Healthcare 17.47%
2 Energy 12.33%
3 Industrials 11.02%
4 Financials 10.54%
5 Technology 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
1
ExxonMobil
XOM
$642B
$11.7M 3.97%
123,908
-12,523
-9% -$1.25M
DHR icon
2
Danaher
DHR
$138B
$5.63M 1.92%
110,229
-10,461
-9% -$538K
GE icon
3
GE Aerospace
GE
$375B
$5.23M 1.78%
42,562
-436
-1% -$54.3K
MA icon
4
Mastercard
MA
$487B
$5.08M 1.73%
68,653
-7,719
-10% -$588K
IBM icon
5
IBM
IBM
$204B
$4.95M 1.69%
27,250
-272
-1% -$49.6K
TMO icon
6
Thermo Fisher Scientific
TMO
$208B
$4.74M 1.62%
38,932
-3,423
-8% -$416K
PG icon
7
Procter & Gamble
PG
$346B
$4.43M 1.51%
52,936
-1,697
-3% -$139K
ECL icon
8
Ecolab
ECL
$76.4B
$3.98M 1.36%
34,661
-3,289
-9% -$370K
CVX icon
9
Chevron
CVX
$378B
$3.94M 1.34%
33,051
-1,958
-6% -$250K
IGSB icon
10
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.9B
$3.63M 1.24%
68,890
+8,452
+14% +$446K
AAPL icon
11
Apple
AAPL
$4.95T
$3.51M 1.2%
139,300
-536
-0.4% -$13.2K
QCOM icon
12
Qualcomm
QCOM
$179B
$3.38M 1.15%
45,148
-1,913
-4% -$146K
MRK icon
13
Merck
MRK
$323B
$3.35M 1.14%
59,299
-1,298
-2% -$72.9K
HSIC icon
14
Henry Schein
HSIC
$9.64B
$3.26M 1.11%
71,433
-8,772
-11% -$407K
ABBV icon
15
AbbVie
ABBV
$454B
$3.2M 1.09%
55,463
-1,942
-3% -$108K
VFC icon
16
VF Corp
VFC
$6.72B
$3.15M 1.08%
50,748
+760
+2% +$45.5K
JNJ icon
17
Johnson & Johnson
JNJ
$641B
$3.11M 1.06%
29,179
-1,860
-6% -$193K
IGIB icon
18
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
$3.11M 1.06%
56,864
+3,436
+6% +$189K
ITW icon
19
Illinois Tool Works
ITW
$81.9B
$3M 1.02%
35,585
-2,887
-8% -$250K
PFE icon
20
Pfizer
PFE
$141B
$2.91M 0.99%
103,630
-3,142
-3% -$88.2K
BAC icon
21
Bank of America
BAC
$436B
$2.91M 0.99%
170,443
-11,582
-6% -$184K
EMR icon
22
Emerson Electric
EMR
$83.6B
$2.74M 0.93%
43,762
+658
+2% +$42.7K
NKE icon
23
Nike
NKE
$62.5B
$2.67M 0.91%
59,754
-3,100
-5% -$123K
SYK icon
24
Stryker
SYK
$129B
$2.63M 0.9%
32,570
-3,100
-9% -$255K
CVS icon
25
CVS Health
CVS
$137B
$2.59M 0.88%
32,490
-1,633
-5% -$129K

Similar funds

Duncker Streett & Co's Q3 2014 Portfolio in Review

As of Q3 2014, Duncker Streett & Co held 649 positions worth $293M, down 5.1% from $309M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Duncker Streett & Co withdrew a net $13.4M in Q3 2014, closing 18 positions and reducing 207 holdings. Its most notable exit was Nucor, an estimated $335K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Energy and Industrials.

Against the trend, Duncker Streett & Co opened a new position in Synchronoss Technologies worth $229K.

  • Duncker Streett & Co's largest Q3 2014 buy was Synchronoss Technologies: 556 shares worth $229K.
  • Duncker Streett & Co added most to SLB Ltd in Q3 2014, an estimated $534K increase.
  • Duncker Streett & Co's biggest Q3 2014 reduction was ExxonMobil, cutting an estimated $1.25M.
  • Duncker Streett & Co fully exited Nucor in Q3 2014, selling an estimated $335K.
  • Duncker Streett & Co's ten largest holdings make up 18% of its $293M portfolio in Q3 2014.
  • Duncker Streett & Co opened 59 new positions and closed 18 in Q3 2014.
  • Duncker Streett & Co's portfolio value fell 5.1% quarter-over-quarter to $293M.

Based on Duncker Streett & Co's 13F filing for Q3 2014, filed 23 Oct 2014.